Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of ENavogliflozin on Coronary microVascular and Cardiac Function in Patients With obesitY (ENVY)

NCT06782139 is registered in ClinicalTrials.gov with Korea University Anam Hospital as lead sponsor.

NCT NCT06782139
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06782139 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of ENavogliflozin on Coronary microVascular and Cardiac Function in Patients With obesitY (ENVY)
Lead sponsor
Korea University Anam Hospital
Phase
Phase 4
Overall status
Recruiting
Start date
January 20, 2025
Completion date
December 31, 2025
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

obesity and type 2 diabetes